Corbion NV is a Netherlands based company that is active in the field of biochemical ingredients. The Company operates through four business lines: Sustainable Food Solutions, which supplies food ingredient solutions to the food manufacturers and encompasses Preservation Solutions, Functional Systems, and Single Ingredients; Lactic Acid & Specialties segment which includes Biochemicals: lactic acid, salts, esters and Biomaterials such as polymers for pharmaceutical, medical, home and personal care, animal health, chemicals and electronics applications; Algae Ingredients segment comprises algae-based ingredients providing nutritional for human and animal diets, such as omega-3; and Incubator segment which develops new biotechnology business platforms.
The Company operates production sites in the United States, Brazil, Mexico, Spain, the Netherlands and Thailand, and markets its products through a global network of retail offices..
Price and Volume | |
---|---|
Volume | |
Ten Day Average Volume | 63.4K |
Three Month Average Volume | 1.5M |
High Low | |
Fifty-Two Week High | 23.02 EUR |
Fifty-Two Week Low | 14.54 EUR |
Fifty-Two Week High Date | 02 Sep 2024 |
Fifty-Two Week Low Date | 26 Oct 2023 |
Price and Volume | |
Current Price | 22.96 EUR |
Beta | 1 |
Relative Price Change | |
Four Week Relative Price Change | 8.81% |
Thirteen Week Relative Price Change | 12.52% |
Twenty-Six Week Relative Price Change | 9.88% |
Fifty-Two Week Relative Price Change | -14.81% |
Year-to-Date Relative Price Change | 1.25% |
Price Change | |
One Day Price Change | 0.44% |
Thirteen Week Price Change | 14.46% |
Twenty-Six Week Price Change | 18.11% |
Five Day Price Change | 6.59% |
Fifty-Two Week Price Change | 5.13% |
Year-to-Date Price Change | 18.47% |
Month-to-Date Price Change | 0.44% |
Per Share Data | |
---|---|
Book Value | |
Book Value Per Share (Last Fiscal Year) | 10.76645 EUR |
Book Value Per Share (Most Recent Quarter) | 12.8243 EUR |
Tangible Book Value Per Share (Last Fiscal Year) | 8.11969 EUR |
Tangible Book Value Per Share (Most Recent Quarter) | 11.10661 EUR |
EBITD | |
EBITD Per Share (Trailing Twelve Months) | 3.76519 EUR |
Revenue | |
Revenue Per Share (Last Fiscal Year) | 24.18425 EUR |
Revenue Per Share (Trailing Twelve Months) | 22.79653 EUR |
Dividend | |
Dividend Per Share (Last Fiscal Year) | 0.6035 EUR |
Dividend Per Share (Trailing Twelve Months) | 0.6035 EUR |
Dividend Per Share (5 Year) | 0.5015 EUR |
Earnings Per Share | |
Excluding Extraordinary Items (Last Fiscal Year) | 1.22111 EUR |
Excluding Extraordinary Items (Trailing Twelve Months) | 1.1447 EUR |
Normalized (Last Fiscal Year) | 1.42714 EUR |
Basic Excluding Extraordinary Items (Last Fiscal Year) | 1.23428 EUR |
Basic Excluding Extraordinary Items (Trailing Twelve Months) | 1.1447 EUR |
Including Extraordinary Items (Last Fiscal Year) | 1.22111 EUR |
Including Extraordinary Items (Trailing Twelve Months) | 3.62574 EUR |
Cash | |
Cash Per Share (Last Fiscal Year) | 1.188 EUR |
Cash Per Share (Most Recent Quarter) | 0.92738 EUR |
Cash Flow Per Share (Last Fiscal Year) | 2.63819 EUR |
Cash Flow Per Share (Trailing Twelve Months) | 2.6414 EUR |
Free Cash Flow Per Share (Trailing Twelve Months) | 0.4159 EUR |
Margins | |
---|---|
Cash Flow Revenue | |
Cash Flow Revenue (5 Year) | -7 |
Cash Flow Revenue (Trailing Twelve Months) | 2 |
Pretax Margin | |
Pretax Margin (Trailing Twelve Months) | 5.65% |
Pretax Margin (Last Fiscal Year) | 5.91% |
Pretax Margin (5 Year) | 7.09% |
Gross Margin | |
Gross Margin (Last Fiscal Year) | 25.90% |
Gross Margin (Trailing Twelve Months) | 26.65% |
Gross Margin (5 Year) | 25.57% |
Operating Margin | |
Operating Margin (Last Fiscal Year) | 8.12% |
Operating Margin (Trailing Twelve Months) | 7.24% |
Operating Margin (5 Year) | 8.01% |
Net Profit Margin | |
Net Profit Margin (Last Fiscal Year) | 5.05% |
Net Profit Margin (Trailing Twelve Months) | 5.03% |
Net Profit Margin (5 Year) | 5.73% |
Growth | |
---|---|
Book Value | |
Book Value Per Share (5 Year) | 3.99% |
Tangible Book Value (5 Year) | 4.72% |
Free Operating Cash Flow | |
Free Operating Cash Flow (5 Year) | -99,999.99% |
Revenue | |
Revenue Change MRQ vs 1 Year Ago | -0.72% |
Revenue Growth (3 Year) | 9.98% |
Revenue Change (Trailing Twelve Months) | -4.91% |
Revenue Per Share Growth | 9.83% |
Revenue Growth (5 Year) | 13.54% |
Capital Spending Debt | |
Capital Spending (5 Year) | 19.96% |
Total Debt (5 Year) | 23.15% |
Dividends | |
Dividend Growth (3 Year) | 8.23% |
Earnings Per Share | |
EPS Change MRQ vs 1 Year Ago | 47.22% |
EPS Change (Trailing Twelve Months) | 25.84% |
EPS Growth (3 Year) | 5.93% |
EPS Growth (5 Year) | -0.20% |
EBITDA | |
EBITDA (5 Year) | 9.99% |
EBITDA (5 Year Interim) | 8.04% |
Net Profit Margin | |
Net Profit Margin Growth (5 Year) | -3.56% |
Valuation | |
---|---|
Total Price to Book | |
Price to Tangible Book (Last Fiscal Year) | 3 |
Price to Tangible Book (Most Recent Quarter) | 2 |
Price to Free Cash Flow | |
Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
Price to Free Cash Per Share (Trailing Twelve Months) | 56 |
Net Debt | |
Net Debt (Most Recent Quarter) | 452.7M |
Net Debt (Last Fiscal Year) | 715.3M |
Price to Sales | |
Price to Sales (Last Fiscal Year) | 1 |
Price to Sales (Trailing Twelve Months) | 1 |
Price to Earnings | |
PE Excluding Extraordinary Items (Last Fiscal Year) | 20 |
PE Normalized (Last Fiscal Year) | 16 |
PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 16 |
PE Excluding Extraordinary Items High (Trailing Twelve Months) | 78 |
PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 16 |
PE Including Extraordinary Items (Trailing Twelve Months) | 6 |
Dividends | |
Dividend Yield (5 Year) | 1.50% |
Dividend Yield | 3.09% |
Current Dividend Yield | 2.63% |
Price to Book | |
Price to Book (Last Fiscal Year) | 2 |
Price to Book (Most Recent Quarter) | 2 |
Financial Strength | |
---|---|
Debt to Equity | |
Long Term Debt to Equity (Last Fiscal Year) | 66 |
Long Term Debt to Equity (Most Recent Quarter) | 56 |
Payout Ratio | |
Payout Ratio (Last Fiscal Year) | 49.38% |
Payout Ratio (Trailing Twelve Months) | 53.33% |
Quick Ratio | |
Quick Ratio (Last Fiscal Year) | 1 |
Quick Ratio (Most Recent Quarter) | 1 |
Enterprise Value | |
Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 193 |
Current Ratio | |
Current Ratio (Last Fiscal Year) | 1 |
Current Ratio (Most Recent Quarter) | 2 |
Free Cash Flow | |
Free Cash Flow (Last Fiscal Year) | -17,000,000 |
Free Cash Flow (Trailing Twelve Months) | 24.5M |
Net Interest Coverage | |
Net Interest Coverage (Last Fiscal Year) | 5 |
Net Interest Coverage (Trailing Twelve Months) | 6 |
Total Debt to Equity | |
Total Debt to Equity (Last Fiscal Year) | 123 |
Total Debt to Equity (Most Recent Quarter) | 67 |
Management Effectiveness | |
---|---|
Return on Assets | |
Return on Assets (Last Fiscal Year) | 4.30% |
Return on Assets (Trailing Twelve Months) | 4.07% |
Return on Assets (5 Year) | 5.20% |
Return on Equity | |
Return on Equity (Last Fiscal Year) | 11.55% |
Return on Equity (Trailing Twelve Months) | 9.79% |
Return on Equity (5 Year) | 12.13% |
Return on Investment | |
Return on Investment (Last Fiscal Year) | 6.59% |
Return on Investment (Trailing Twelve Months) | 5.83% |
Return on Investment (5 Year) | 7.36% |